Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | CAFFEINE (M+H)+ | 104897 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+H)+ | 125027 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+H)+ | 276367 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+H)+ | 634240 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+H)+ | 1105448 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+H)+ | 1709525 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+H)+ | 2524314 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+H)+ | 2656248 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+H)+ | 2746033 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+H)+ | 4051323 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+H)+ | 4190574 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+H)+ | 5827904 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+H)+ | 8484092 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+H)+ | 8647400 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+NA)+ | 2644 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+NA)+ | 7413 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+NA)+ | 14688 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+NA)+ | 30833 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+NA)+ | 38628 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+NA)+ | 52812 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+NA)+ | 55197 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+NA)+ | 62130 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+NA)+ | 83319 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+NA)+ | 86172 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+NA)+ | 106785 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+NA)+ | 153218 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+NA)+ | 175178 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CAFFEINE (M+NA)+ | Peak area normalized | male | pre-diabetic | Neuropathy |